Terms: = Lung cancer AND OMD, osteoadherin, 4958, ENSG00000127083, Q99983, SLRR2C AND Staging
4 results:
1. Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment - A multicenter analysis.
Frost N; Roeper J; Velthaus JL; Raspe M; Olive E; Schmittel A; Schmidt B; Wasilewski D; Onken J; Lüders H; Witzenrath M; Senger C; Böhmer D; Loges S; Griesinger F; Modest DP; Grohé C
Lung Cancer; 2022 Aug; 170():165-175. PubMed ID: 35803041
[TBL] [Abstract] [Full Text] [Related]
2. Disease Burden on PET Predicts Outcomes for Advanced NSCLC Patients Treated with First-Line Immunotherapy.
Andraos TY; Halmos B; Cheng H; Huntzinger C; Shirvani SM; Ohri N
Clin Lung Cancer; 2022 Jun; 23(4):291-299. PubMed ID: 35382980
[TBL] [Abstract] [Full Text] [Related]
3. A Prediction Model to Optimize Invasive Mediastinal staging Procedures for Non-small Cell lung cancer in Patients With a Radiologically Normal Mediastinum: The Quebec Prediction Model.
Guinde J; Bourdages-Pageau E; Collin-Castonguay MM; Laflamme L; Lévesque-Laplante A; Marcoux S; Roy P; Ugalde PA; Lacasse Y; Fortin M
Chest; 2021 Dec; 160(6):2283-2292. PubMed ID: 34119514
[TBL] [Abstract] [Full Text] [Related]
4. EORTC lung cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.
Levy A; Hendriks LEL; Berghmans T; Faivre-Finn C; GiajLevra M; GiajLevra N; Hasan B; Pochesci A; Girard N; Greillier L; Lantuéjoul S; Edwards J; O'Brien M; Reck M; Besse B; Novello S; Dingemans AC;
Eur J Cancer; 2019 Nov; 122():109-114. PubMed ID: 31671363
[TBL] [Abstract] [Full Text] [Related]
